Effect of a lowering blood glucose drug on protein loss with urine in patient with kidney disease due to diabet

Phase 3

• Conditions: Diabetic nephropathy.; Diabetes mellitus With renal complications; E10-E14 :

• Registration Number: IRCT2013102115105N1
• Lead Sponsor: Vice chancellor for research, Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

(The patient with Diabetic nephropathy with Diabet type2; Glomerular filtration rate equal or greater than 30; Age graeter 18 & smaller 65 years old; Agreement to participate in the study) Exclusion criteria: (Glomerular Filtration Rate smaller than 30; Dyspnea; CHF; Liver failure; General edema; Age smaller than 18 & greater than 65 years old; Body Mass Index equal or greater than 40

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proteinuria. Timepoint: Monthly. Method of measurement: 24 urin and according to miligram per deciliter.

Secondary Outcome Measures

Name	Time	Method
Ferritin. Timepoint: Monthly. Method of measurement: Elisa and according to Nanogram per mililiter.;High sensitivity C- Reactive protein. Timepoint: Monthly. Method of measurement: Elisa according to Nanogram per mililiter.;Malondialdehyde. Timepoint: Monthly. Method of measurement: Elisa and according to micromol per liter.;Total antioxidant. Timepoint: Monthly. Method of measurement: Elisa and according to microgram per mililiter.